SELADELPAR, A PPAR-DELTA AGONIST, IMPROVES INFLAMMATORY LIPID MEDIATORS IN THE SERUM METABOLOME IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC)-MedSci.cn

SELADELPAR, A PPAR-DELTA AGONIST, IMPROVES INFLAMMATORY LIPID MEDIATORS IN THE SERUM METABOLOME IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC)

Choi, YJ; Johnson, JD; Schwab, A; McWherter, C

HEPATOLOGY, 2022; 76 (): S1487

科室
- - 订阅+
  - 更多科室
工具
服务